Key Highlights
● Moderna rocketed on Friday, closing at $225.00, up $28.00, at the top of its day's range of $197.17 to $225.00.
● Volume reached about 28.9 million shares against an average of roughly 17.7 million, with the close its highest since 2021.
● Moderna officially joined the Nasdaq-100 that morning, replacing Warner Bros. Discovery, alongside a media report on an NIH cancer-vaccine initiative.
● Novavax soared, BioNTech rose to $92.44 and Arcturus climbed after Leerink Partners raised its price target to $19 from $13.
Moderna (NASDAQ:MRNA) rocketed on Friday, closing at $225.00, up $28.00, at the very top of its day's range of $197.17 to $225.00. Volume reached about 28.9 million shares, well above its average of roughly 17.7 million, according to market data. The close left the shares at their highest level since 2021, according to market data.
The surge came on the morning Moderna officially joined the Nasdaq-100, replacing Warner Bros. Discovery (NASDAQ:WBD), and alongside a media report on a public-private initiative involving the National Institutes of Health to accelerate cancer Vaccine research.
The NIH report
According to the media report, the NIH plans a public-private campaign starting in December to fast-track research into cancer treatments, with an initial focus on pancreatic, liver and colorectal cancers as well as some childhood tumors. The initiative aims to replicate the success of the effort that produced Covid-19 vaccines.
That matters for Moderna, whose messenger RNA technology was at the heart of its Covid-19 vaccine and which has been developing individualized cancer vaccines. Several market reports linked Friday's move to the report, while one live commentary tied it instead to Moderna rejoining the Nasdaq-100.
Index entry and fund buying
Joining the Nasdaq-100 means funds that track the index, including some of the largest Exchange-traded funds in the world, need to hold the stock. Such buying usually happens around the effective date, which can add to volume. The Nasdaq-100 itself rose 157.34 points to 30,883.15 on Friday.
A rally across vaccine and biotech names
Moderna was not alone. Novavax (NASDAQ:NVAX) soared, BioNTech (NASDAQ:BNTX) rose to $92.44 and Arcturus Therapeutics (NASDAQ:ARCT) climbed after Leerink Partners raised its price target to $19 from $13. Ginkgo Bioworks (NYSE:DNA), Twist Bioscience (NASDAQ:TWST), Recursion and Tempus (NASDAQ:TEM) also gained, according to market data. Larger drugmakers Pfizer (NYSE:PFE), Merck (NYSE:MRK) and Gilead (NASDAQ:GILD) rose too, and health care was the S&P 500's second-best sector on the day, behind real estate.
Some coverage was more cautious about the scope of the rally. One market report said no company-specific announcement, filing or trial result explained the move in Novavax shares, a reminder that thematic moves can lift a whole group regardless of individual fundamentals.
A supportive market
The broader backdrop was positive. The S&P 500 rose 46.18 points to 7,811.54, the Dow climbed 423.31 points to 51,654.95 and the Nasdaq Composite gained 172.83 points to 27,366.17. Software rebounded after Thursday's AI sell-off, and Humana (NYSE:HUM) surged after favorable Medicare Advantage star ratings.
Still, rates remain a risk for richly valued growth stocks. The 10-year Treasury Yield held near a 24-year high, and the Fed raised rates in September for the first time since 2023. Fed Governor Christopher Waller said Thursday he anticipates additional hikes to bring Inflation back to the Fed's goal.
Official NIH Details and Johnson & Johnson's Earnings Are Moderna's Next Catalysts
Stocks trade on Monday, October 12, Columbus Day, while the Bond Market is closed. September consumer prices arrive Wednesday, October 14, followed by producer prices and retail sales on Thursday. Bank earnings begin Tuesday, and Johnson & Johnson (NYSE:JNJ) reports the same morning, an early read on health care. The Fed meets October 27–28. For Moderna, investors will look for official details of the NIH initiative ahead of its expected December start, including which companies take part.



_11_19_2026_18_10_09_455845.jpg)

_11_19_2026_18_15_38_890267.jpg)
Please wait processing your request...